Moreover, in NSCLC, IFN-γ upregulates IL-12 expression, whereas IL-4 downregulates it in LAMP3+ DCs; blocking IL-4 enhances IL-12 production and expands the population of IFN-γ+ CD8+ T effector cells [85]. This evidence concerns the gene IFNG and non-small cell lung carcinoma.